FormulaFolio Investments’s Biogen BIIB Stock Holding History

FormulaFolio Investments’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$3K	Hold	9	–	–	﹤0.01%	387
2021 Q1	$3K	Buy	+9	New	+$2.43K	﹤0.01%	372
2020 Q3	–	Sell	-906	Closed	-$242K	–	317
2020 Q2	$242K	Sell	906 -280	-24%	-$84.2K	0.01%	256
2020 Q1	$375K	Sell	1,186 -1,272	-52%	-$386K	0.02%	197
2019 Q4	$729K	Buy	+2,458	New	+$682K	0.03%	207
2019 Q3	–	Sell	-2,921	Closed	-$683K	–	342
2019 Q2	$683K	Buy	2,921 +840	+40%	+$194K	0.03%	173
2019 Q1	$492K	Buy	+2,081	New	+$655K	0.02%	195

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

FormulaFolio Investments's BIIB Position: Q2 2021 in Review

FormulaFolio Investments held its Biogen (BIIB) position steady in Q2 2021 at 9 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #387.

FormulaFolio Investments first reported a position in BIIB in Q1 2019 and has held it in 7 quarters since. The position peaked at $729K in Q4 2019. 1,104 funds tracked by Wall St. Rank hold BIIB as of Q2 2021.

FormulaFolio Investments held 9 shares of Biogen worth $3K as of Q2 2021.
FormulaFolio Investments left its Biogen share count unchanged in Q2 2021.
Biogen made up ﹤0.01% of FormulaFolio Investments's portfolio in Q2 2021, its #387 holding.
FormulaFolio Investments first reported a position in Biogen in Q1 2019 and has held it in 7 quarters since.
FormulaFolio Investments's Biogen position peaked at $729K in Q4 2019.
1,104 funds tracked by Wall St. Rank held Biogen as of Q2 2021.

Based on FormulaFolio Investments's 13F filing for Q2 2021, filed 28 Jul 2021.